Investigation of docosahexaenoic acid as a treatment for particle-induced inflammation

NIH RePORTER · NIH · F31 · $36,828 · view on reporter.nih.gov ↗

Abstract

Abstract Acute and chronic inflammation are vital contributing factors to pulmonary diseases which can be triggered by the exposure to airborne toxicants such as silica and nanomaterials. There has been an increasing trend in the use of nanomaterials in various consumer products that in turn will increase the risk of pulmonary diseases. Unfortunately, there is a lack of preventative and therapeutic treatments in these diseases, in part due to a lack of understanding of key events that need to be addressed. A potential treatment that has been shown to have anti-inflammatory effects is the common dietary supplement docosahexaenoic acid (DHA); an omega-3 polyunsaturated fatty acid most commonly found in fish oil. DHA will be investigated in this proposal as both a therapeutic treatment and a prophylactic for particle-induced inflammation. Macrophages are important regulators in an immune response to inhaled foreign materials, such as silica and nanomaterials, in order to maintain homeostasis. Macrophage functions are dependent upon various signaling factors which generate different macrophage phenotypes such as pro-inflammatory classically activated M1 and anti-inflammatory alternatively activated M2 as well as the additional subsets of M2a, M2b, M2c, and M2d. Our preliminary studies and current literature suggest that DHA induces M2 macrophage phenotype polarization. Signaling factors determine which macrophage phenotype is dominant to regulate the overall response to foreign particles. I propose that exposure to various particles cause phagolysosomal membrane permeability (LMP). LMP results in cathepsin B release into the cytosol, which activates the NLRP3 inflammasome. This activation triggers active caspase-1 and leads to interleukin-1b and -18 secretion resulting in inflammation. This research will investigate the mechanisms by which DHA functions as an anti-inflammatory dietary supplement in regard to particle- induced inflammation by characterizing the impact of DHA on macrophage phenotypes and LMP. This research being performed in a nurturing environment, along with my customized training plan and the guidance of my mentor, will assist me in becoming a successful independent researcher in the future.

Key facts

NIH application ID
9830644
Project number
5F31ES028100-03
Recipient
UNIVERSITY OF MONTANA
Principal Investigator
Paige Fletcher
Activity code
F31
Funding institute
NIH
Fiscal year
2020
Award amount
$36,828
Award type
5
Project period
2017-12-01 → 2020-11-30